Frontline Daratumumab Triplet Demonstrates Durability in Octogenarians but Early Infections Pose Risk
A retrospective study reveals that frontline daratumumab, lenalidomide, and dexamethasone provided durable disease control in transplant-ineligible multiple myeloma patients older ...




